TrialJAMA2024

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.

Richard M Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.